Desonide
-
Desonide
structure -
-
CAS No:
638-94-8
-
Formula:
C24H32O6
-
Chemical Name:
Desonide
-
Synonyms:
Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11β,16α)-;Pregna-1,4-diene-3,20-dione,11β,16α,17,21-tetrahydroxy-,cyclic 16,17-acetal with acetone;2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole,pregna-1,4-diene-3,20-dione deriv.;(11β,16α)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione;16α-Hydroxyprednisolone 16α,17α-acetonide;Desonide;Prednacinolone;16α-Hydroxyprednisolone acetonide;11β,16α,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide;Tridesilon;16α-Hydroxyprednisolone 16,17-acetonide;16α,17α-(Isopropylidenedioxy)prednisolone;Steroderm;11β,21-Dihydroxy-16α,17α-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione;Prednacinolone acetonide;Apolar;D 2083;Locapred;Topifug;Sterax;Budesonide acetonide;Prenacid;Tridesonit;Prednisolone acetonide;Desowen;24814-50-4;63905-08-8
- Categories:
-
CAS No:
Description
Desonide is a nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.Target: Glucocorticoid ReceptorDesonide is a low-potency topical corticosteroid that has been used for decades in the treatment of steroid-responsive dermatoses [1]. Desonide induced significant colorimetric improvement compared with placebo. A good to excellent response was achieved in 30% for desonide, and 6% for placebo. Decreased pigmentation in the desonide-treated axillae was associate
Characteristics
93.06000
2.32670
Powder
1.3 g/cm3
274 °C
580.1ºC at 760 mmHg
196.9ºC
1.598
Refrigerator
LD50 in rats (mg/kg): 93 s.c. (Phillips)
Drug Function and Efficacy
This product is a glucocorticoid drug with anti-inflammatory, anti-allergic, antipruritic and exudation-reducing effects; it can reduce and prevent tissue response to inflammation, eliminate fever, redness and swelling caused by local non-infectious inflammation, thereby reducing the manifestations of inflammation; it has an immunosuppressive effect of preventing or inhibiting cellular immune responses and suppressing primary immune responses.
Registered Holders
-
AARTI PHARMALABS LTD
Active
United States
-
TAPI NL B.V.
Active
France
-
Chongqing Shengkai Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Desonide
-
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional SupplementsInquiryCAS No.: 638-94-8Grade: Pharmaceutical GradeContent: 99.5% -
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials,Fine Chemicals,Synthetic customization -
CN
4 YRS
Business licensedTrader Supplier of Semaglutide,Tirzepatide,API,EnzymeInquiryCAS No.: 638-94-8Grade: Pharmaceutical GradeContent: 99.5% -
HK
2 YRS
Business licensedTrader Supplier of PeptidesInquiryCAS No.: 638-94-8Grade: Industrial GradeContent: 99% -
CN
2 YRS
Business licensedTrader Supplier of API,Antibiotics,Anti cancer categoryInquiryUnit Price: $50 /MT EXWCAS No.: 638-94-8Grade: Pharmaceutical GradeContent: 99%
Latest News on Desonide
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4